|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| AMG | Alvingham Karen L. | Director | Nov 07 '25 | Option Exercise | 69.63 | 560 | 38,993 | 12,425 | Nov 12 04:56 PM |
| AMG | Alvingham Karen L. | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,092 | 0 | 11,949 | Aug 18 05:11 PM |
| AMG | Alvingham Karen L. | Director | Mar 05 '25 | Option Exercise | 0.00 | 1,178 | 0 | 10,947 | Mar 07 05:07 PM |
| AMG | Alvingham Karen L. | Director | Aug 15 '24 | Option Exercise | 0.00 | 928 | 0 | 9,841 | Aug 16 05:01 PM |
| AMG | Alvingham Karen L. | Director | Jul 31 '24 | Option Exercise | 96.16 | 10,438 | 1,003,693 | 14,700 | Jul 31 06:52 PM |
| AMG | Alvingham Karen L. | Director | Mar 05 '24 | Option Exercise | 0.00 | 537 | 0 | 4,303 | Mar 07 05:31 PM |
| AMG | Alvingham Karen L. | Director | Jan 01 '24 | Option Exercise | 0.00 | 122 | 0 | 3,775 | Jan 03 05:23 PM |
| AMG | Alvingham Karen L. | Director | Aug 15 '23 | Option Exercise | 0.00 | 753 | 0 | 3,711 | Aug 17 05:03 PM |
| AMG | Alvingham Karen L. | Director | Mar 05 '23 | Option Exercise | 0.00 | 392 | 0 | 2,988 | Mar 07 05:35 PM |
| AMG | Alvingham Karen L. | Director | Jan 01 '23 | Option Exercise | 0.00 | 329 | 0 | 2,621 | Jan 04 05:32 PM |
| AMG | Alvingham Karen L. | Director | Aug 15 '22 | Option Exercise | 0.00 | 559 | 0 | 2,333 | Aug 17 05:06 PM |
| AMG | Alvingham Karen L. | Director | Mar 05 '22 | Option Exercise | 0.00 | 220 | 0 | 1,791 | Mar 08 05:58 PM |
| AMG | Alvingham Karen L. | Director | Jan 01 '22 | Option Exercise | 0.00 | 441 | 0 | 1,605 | Jan 04 05:16 PM |
| AMG | Alvingham Karen L. | Director | Aug 15 '21 | Option Exercise | 0.00 | 382 | 0 | 1,189 | Aug 17 05:08 PM |
| AMG | Yerburgh Karen | Director | Jan 01 '21 | Option Exercise | 0.00 | 439 | 0 | 837 | Jan 05 05:04 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite